Dare Bioscience, Inc. Increase (Decrease) in Contract with Customer, Liability
Dare Bioscience, Inc. (DARE) reported Increase (Decrease) in Contract with Customer, Liability of $205.21 thousand for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInContractWithCustomerLiability · last filed 2023-11-09
- Dare Bioscience, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2023-09-30 was $0.00.
- Dare Bioscience, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2022-09-30 was $0.00.
- Dare Bioscience, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2021-12-31 was $0.00.
- Dare Bioscience, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2021-09-30 was $0.00.
- Dare Bioscience, Inc. increase (decrease) in contract with customer, liability for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- Dare Bioscience, Inc. increase (decrease) in contract with customer, liability for fiscal 2020 was $1.00M.
- Dare Bioscience, Inc. increase (decrease) in contract with customer, liability for fiscal 2019 was $0.00.
| Period end | Increase (Decrease) in Contract with Customer, Liability 3 month | Increase (Decrease) in Contract with Customer, Liability 6 month | Increase (Decrease) in Contract with Customer, Liability 9 month | Increase (Decrease) in Contract with Customer, Liability 12 month |
|---|---|---|---|---|
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $205.21K 10-Q · filed 2023-11-09 | ||
| 2023-06-30 | $205.21K 10-Q · filed 2023-08-10 | |||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $0.00 10-Q · filed 2023-11-09 | ||
| 2022-06-30 | $0.00 10-Q · filed 2023-08-10 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $0.00 derived: sum of 2 quarters · filed 2022-03-31 | $0.00 derived: sum of 3 quarters · filed 2022-03-31 | $0.00 10-K · filed 2022-03-31 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $0.00 derived: sum of 2 quarters · filed 2021-11-10 | $0.00 10-Q · filed 2021-11-10 | $0.00 derived: sum of 4 quarters · filed 2022-03-31 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $0.00 10-Q · filed 2021-08-12 | $0.00 derived: sum of 3 quarters · filed 2022-03-31 | $0.00 derived: sum of 4 quarters · filed 2022-03-31 |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-13 | $0.00 derived: sum of 2 quarters · filed 2022-03-31 | $0.00 derived: sum of 3 quarters · filed 2022-03-31 | $0.00 derived: sum of 4 quarters · filed 2022-03-31 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $0.00 derived: sum of 2 quarters · filed 2022-03-31 | $0.00 derived: sum of 3 quarters · filed 2022-03-31 | $1.00M 10-K · filed 2022-03-31 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $0.00 derived: sum of 2 quarters · filed 2021-11-10 | $1.00M 10-Q · filed 2021-11-10 | $1.00M derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $1.00M 10-Q · filed 2021-08-12 | $1.00M derived: sum of 3 quarters · filed 2021-08-12 | $1.00M derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | $1.00M 10-Q · filed 2021-05-13 | $1.00M derived: sum of 2 quarters · filed 2021-05-13 | $1.00M derived: sum of 3 quarters · filed 2021-05-13 | $1.00M derived: sum of 4 quarters · filed 2021-05-13 |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | $0.00 derived: sum of 2 quarters · filed 2021-03-30 | $0.00 derived: sum of 3 quarters · filed 2021-03-30 | $0.00 10-K · filed 2021-03-30 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $0.00 derived: sum of 2 quarters · filed 2020-11-12 | $0.00 10-Q · filed 2020-11-12 | |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | $0.00 10-Q · filed 2020-08-12 | ||
| 2019-03-31 | $0.00 10-Q · filed 2020-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |